We are live on ! Find out more
VF

Virtu Financial Portfolio holdings

AUM $3.18B
1-Year Est. Return 65.92%
This Fund
S&P 500
This Quarter Est. Return
+9.13%
1 Year Est. Return
+65.92%
3 Year Est. Return
+160.27%
5 Year Est. Return
+179.96%
10 Year Est. Return
AUM
$1.03B
AUM Growth
-$383M
Cap. Flow
-$421M
Cap. Flow %
-40.89%
Top 10 Hldgs %
24.29%
Holding
2,439
New
893
Increased
254
Reduced
276
Closed
993

Sector Composition

Rank Sector Weight
1 Technology 10.93%
2 Healthcare 10.76%
3 Consumer Discretionary 9.35%
4 Communication Services 9.1%
5 Financials 8.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TMBR
1251
DELISTED
Timber Pharmaceuticals, Inc.
TMBR
$80K 0.01%
+1,318
New +$92.6K
BLPH
1252
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
$80K 0.01%
+16,495
New +$74K
ADIL
1253
Adial Pharmaceuticals
ADIL
$9.61M
$79K 0.01%
+50
New +$76.1K
DSS icon
1254
DSS Inc
DSS
$5.18M
$79K 0.01%
2,372
-4,433
-65% -$226K
WHWK
1255
Whitehawk Therapeutics
WHWK
$267M
$79K 0.01%
3,125
-2,362
-43% -$54K
OBSV
1256
DELISTED
ObsEva SA Ordinary Shares
OBSV
$79K 0.01%
+25,964
New +$76.4K
USIO icon
1257
Usio Inc
USIO
$71.5M
$78K 0.01%
+12,194
New +$76.1K
AUC
1258
ATIF Holdings
AUC
$69M
$78K 0.01%
+972
New +$91.4K
SNES icon
1259
SenesTech
SNES
$6.78M
$77K 0.01%
20
-25
-56% -$97K
YCBD icon
1260
cbdMD
YCBD
$5.93M
$77K 0.01%
+74
New +$88.5K
VYNT
1261
DELISTED
Vyant Bio, Inc. Common Stock
VYNT
$77K 0.01%
4,101
-3,741
-48% -$69.7K
CPRX
1262
DELISTED
Catalyst Pharmaceutical
CPRX
$76K 0.01%
+13,295
New +$68.6K
TOON icon
1263
Kartoon Studios
TOON
$38.2M
$76K 0.01%
4,107
-69,010
-94% -$1.21M
MTCR
1264
DELISTED
Metacrine, Inc. Common Stock
MTCR
$75K 0.01%
+19,671
New +$81.3K
AQST icon
1265
Aquestive Therapeutics
AQST
$533M
$74K 0.01%
+18,521
New +$74K
BKYI
1266
BIO-key International
BKYI
$4.1M
$74K 0.01%
+108
New +$71K
PALI icon
1267
Palisade Bio
PALI
$375M
$74K 0.01%
24
-6
-20% -$27.2K
GRDX
1268
GridAI Technologies Corp
GRDX
$26.8M
$74K 0.01%
1
MTL
1269
DELISTED
Mechel PAO American Depository Shares, each representing two ordinary shares (ADSs)
MTL
$74K 0.01%
+36,628
New +$75K
GGB icon
1270
Gerdau
GGB
$9.42B
$73K 0.01%
15,652
-563,586
-97% -$2.76M
PPSI
1271
Pioneer Power Solutions
PPSI
$33.5M
$73K 0.01%
+15,658
New +$65K
SONM icon
1272
DNA X Inc
SONM
$5.05M
$73K 0.01%
73
+56
+329% +$60.9K
AUD
1273
DELISTED
Audacy, Inc.
AUD
$72K 0.01%
+16,719
New +$76.8K
PRSO icon
1274
Peraso
PRSO
$10.3M
$71K 0.01%
+283
New +$56.4K
UEC icon
1275
Uranium Energy
UEC
$5.54B
$71K 0.01%
26,814
-152,128
-85% -$458K

Similar funds

Virtu Financial's Q2 2021 Portfolio in Review

As of Q2 2021, Virtu Financial held 2,439 positions worth $1.03B, down 27% from $1.41B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Virtu Financial withdrew a net $421M in Q2 2021, closing 993 positions and reducing 276 holdings. Its most notable exit was SPDR Gold Trust, an estimated $213M position sold in full.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 9.8% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Virtu Financial opened a new position in PRA Health Sciences, Inc. worth $111M.

  • Virtu Financial's largest Q2 2021 buy was PRA Health Sciences, Inc.: 668,921 shares worth $111M.
  • Virtu Financial added most to Alphabet (Google) Class A in Q2 2021, an estimated $16.1M increase.
  • Virtu Financial's biggest Q2 2021 reduction was Berkshire Hathaway Class B, cutting an estimated $56.6M.
  • Virtu Financial fully exited SPDR Gold Trust in Q2 2021, selling an estimated $213M.
  • Virtu Financial's ten largest holdings make up 24% of its $1.03B portfolio in Q2 2021.
  • Virtu Financial opened 893 new positions and closed 993 in Q2 2021.
  • Virtu Financial's portfolio value fell 27% quarter-over-quarter to $1.03B.

Based on Virtu Financial's 13F filing for Q2 2021, filed 17 Sep 2021.